RESEARCH / DISCOVERY
← Back to the library

Parkinson-Krankheit und atypische Parkinson-Syndrome

Parkinson-Krankheit und atypische Parkinson-Syndrome

Read the original publication

A plain-language reading has not been prepared for this paper yet.

Original abstract

Parkinson’s disease is the most common neurodegenerative disease after Alzheimer’s disease and belongs to the group of hypokinetic movement disorders. Atypical parkinsonian disorders represent a pathologically inhomogeneous group of rare neurodegenerative disorders which, compared to Parkinson’s disease, are characterized by a more malignant course and poorer therapeutic response. Neuroprotective or disease-modifying therapies are neither available for Parkinson’s disease nor for atypical parkinsonian disorders. The most effective substance for symptomatic therapy is still levodopa. Invasive therapy options available for Parkinson’s disease are not used in atypical parkinsonian disorders.

Explore another example or bring your own paper

Pasted text and PDF extraction stay on this computer. The local guide explains terms and surfaces passages; rewriting requires a configured local model. Scanned PDFs need OCR first.

RECORD & PROVENANCE